Published Dec 26, 2019
Machine Learning: A New Approach to Drug Discovery with Daphne Koller - #332
Daphne Koller, co-founder of Coursera and CEO of Insitro, delves into the revolutionary role of machine learning in drug discovery, highlighting its potential to transform precision medicine by overcoming industry challenges and enhancing treatment effectiveness. Her discussion emphasizes the importance of integrating AI with biology and the value of cross-functional collaboration in navigating pharmaceutical complexities.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Machine Learning at GSK with Kim Branson - #536
Answers 383 questions
Machine Learning as a Software Engineering Discipline with Dillon Erb - #404
Answers 383 questions
Automated Machine Learning with Erez Barak - #323
Answers 383 questions
Quantum Machine Learning: The Next Frontier? - With Iordanis Kerenidis - #397
Answers 383 questions
Open-Source Drug Discovery with DeepChem with Bharath Ramsundar - #566
Answers 383 questions
Machine Learning at GitHub with Omoju Miller - #313
Answers 383 questions
Machine Learning for Equitable Healthcare Outcomes with Irene Chen - #479
Answers 383 questions
Predicting Metabolic Pathway Dynamics with Machine Learning, w/ Zak Costello - #163
Answers 383 questionsCompositional ML and the Future of Software Development with Dillon Erb - #520
Answers 383 questions
Engineering Practical Machine Learning Systems with Xavier Amatriain - #3
Answers 383 questions
Systems and Software for Machine Learning at Scale with Jeff Dean - #124
Answers 383 questions
Deep Learning for Live-Cell Imaging with David Van Valen - #141
Answers 383 questions
Machine Learning for Earthquake Seismology with Karianne Bergen - #554
Answers 383 questions
Cell Exploration with ML at the Allen Institute w/ Jianxu Chen - #383
Answers 383 questions
